Trials / Completed
CompletedNCT01052779
A Trial Comparing Ferumoxytol to Iron Sucrose for the Treatment of Iron Deficiency Anemia in Adult Subjects With Chronic Kidney Disease
Ferumoxytol Compared to Iron Sucrose Trial (FIRST): A Randomized, Multicenter, Trial of Ferumoxytol Compared to Iron Sucrose for the Treatment of Iron Deficiency Anemia in Adult Subjects With Chronic Kidney Disease
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 162 (actual)
- Sponsor
- AMAG Pharmaceuticals, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to evaluate the safety and efficacy of intravenous (IV) ferumoxytol compared to IV iron sucrose for the treatment of iron deficiency anemia (IDA) in participants with chronic kidney disease (CKD).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ferumoxytol | IV Ferumoxytol |
| DRUG | Iron Sucrose | IV Iron Sucrose |
Timeline
- Start date
- 2010-03-01
- Primary completion
- 2011-07-19
- Completion
- 2012-04-19
- First posted
- 2010-01-20
- Last updated
- 2023-07-25
- Results posted
- 2018-05-15
Locations
36 sites across 7 countries: United States, Belgium, Canada, Germany, India, Poland, United Kingdom
Source: ClinicalTrials.gov record NCT01052779. Inclusion in this directory is not an endorsement.